Hormonal Cancer Laboratory (HCL)
Matt Burow, Ph.D.
Dr. Burow received his B.S. in Biology in 1994 at the University of Southern Mississippi. He completed his Ph.D. in 1998 at Tulane University from the Interdisciplinary Graduate Program in Molecular and Cellular Biology. Dr. Burow carried out his post-doctoral studies with Dr. John McLachlan at the Tulane/Xavier Center for Bioenvironmental Research. He was appointed in 2000 as a Research Assistant Professor in the Department of Pharmacology. In 2002 Dr. Burow accepted his current position as an Assistant Professor in the Section of Hematology and Medical Oncology, Department of Medicine with an appointment as an Adjunct Assistant Professor in the Department of Surgery. Dr. Burow's primary research interests focus on understanding the molecular mechanisms that control estrogen receptor mediated gene expression and anti-estrogen resistance in breast carcinoma cells and the way that cell survival and apoptotic signaling pathways regulate the progression of breast carcinoma to a hormone independent and drug resistant phenotype.